ResearcherPennsylvania State UniversityNo recent work listed
Amanda Beth Cooper
Matched on ORCID iD 0000-0003-3975-3897; OpenAlex author ID A5020132524. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2013: 1 paper · 2014: 1 paper · 2015: 2 papers
Papers 4
- Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates? Co-author DOI 10.1007/s11605-014-2620-3↗
- Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-014-4285-2↗
- Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. Co-author DOI 10.1016/j.jamcollsurg.2014.02.023↗
- Treatment of borderline resectable pancreatic cancer. Co-author DOI 10.1007/s11864-013-0244-6↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthew H. G. Katz · 4 shared papers, 2013–2015 · strength 0.20
- Paper Treatment of borderline resectable pancreatic cancer. DOI 10.1007/s11864-013-0244-6↗
- Paper Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates? DOI 10.1007/s11605-014-2620-3↗
- Paper Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. DOI 10.1016/j.jamcollsurg.2014.02.023↗
- Nathan H. Parker · 2 shared papers, 2014–2015 · strength 0.08
- Paper Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. DOI 10.1016/j.jamcollsurg.2014.02.023↗
- Paper Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic … DOI 10.1245/s10434-014-4285-2↗
- Jean‐Nicolas Vauthey · 2 shared papers, 2014–2015 · strength 0.08
- Paper Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. DOI 10.1016/j.jamcollsurg.2014.02.023↗
- Paper Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic … DOI 10.1245/s10434-014-4285-2↗
- Jason B. Fleming · 2 shared papers, 2014–2015 · strength 0.08
- Paper Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. DOI 10.1016/j.jamcollsurg.2014.02.023↗
- Paper Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic … DOI 10.1245/s10434-014-4285-2↗
- David R. Fogelman · 2 shared papers, 2014–2015 · strength 0.08
- Paper Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. DOI 10.1016/j.jamcollsurg.2014.02.023↗
- Paper Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic … DOI 10.1245/s10434-014-4285-2↗
- Jeffrey E. Lee · 2 shared papers, 2014–2015 · strength 0.08
- Paper Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. DOI 10.1016/j.jamcollsurg.2014.02.023↗
- Paper Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic … DOI 10.1245/s10434-014-4285-2↗
- Ching-Wei David Tzeng · 1 shared paper, 2013 · strength 0.06
- Taylor Sohn Riall · 1 shared paper, 2015 · strength 0.06
- Abhishek D. Parmar · 1 shared paper, 2015 · strength 0.06
- Henry Anthony Pitt · 1 shared paper, 2015 · strength 0.06
- An Ngo‐Huang · 1 shared paper, 2015 · strength 0.04
- Aparna Balachandran · 1 shared paper, 2015 · strength 0.04
- Maria Q. B. Petzel · 1 shared paper, 2015 · strength 0.04
- Claudius H. Conrad · 1 shared paper, 2015 · strength 0.04
- Douglas B. Evans · 1 shared paper, 2015 · strength 0.04
- Gauri Rajani Varadhachary · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.